Search Results

Combination pharmaceutical therapies for obesity

Authors: Gadde, Kishore M; Allison, David B

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 6, April 2009 , pp. 921-925(5)

Publisher: Informa Healthcare

Obesity: Pathophysiology and Clinical Management

Authors: Gurevich-Panigrahi, Tatiana; Panigrahi, Soumya; Wiechec, Emilia; Los, Marek

Source: Current Medicinal Chemistry, Volume 16, Number 4, February 2009 , pp. 506-521(16)

Publisher: Bentham Science Publishers

Phentermine: Heart arrest and myocardial infarction: case report

Source: Reactions, Volume 1, Number 1211, 2008-07-19 , pp. 26-27(2)

Publisher: Adis International

Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy

Author: Atkinson, T. J.

Source: Obesity Reviews, Volume 9, Number 2, March 2008 , pp. 108-120(13)

Publisher: Blackwell Publishing

US product approvals

Source: Inpharma, Volume 1, Number 1619, 2008-01-05 , pp. 18-18(1)

Publisher: Adis International

R&D news from NAASO

Source: Inpharma, Volume 1, Number 1615, 2007-11-24 , pp. 14-14(1)

Publisher: Adis International

Phentermine/sibutramine: Myocardial infarction (first report with sibutramine): 2 case reports

Source: Reactions, Volume 1, Number 1177, 2007-11-10 , pp. 23-23(1)

Publisher: Adis International

Phentermine/topiramate slims CV risk factors in obese patients

Source: Inpharma, Volume 1, Number 1610, 2007-10-20 , pp. 10-10(1)

Publisher: Adis International

US product approvals

Source: Inpharma, Volume 1, Number 1603, 2007-09-01 , pp. 18-18(1)

Publisher: Adis International

A phentermine/fluoxetine combination is not as effective as phentermine/fenfluramine for weight loss among obese patients, but is also not associated with cardiac valve lesions

Source: Inpharma, Volume 1, Number 1594, 2007-06-30 , pp. 15-15(1)

Publisher: Adis International

A phentermine/fluoxetine combination is not as effective as phentermine/fenfluramine for weight loss among obese patients, but is also not associated with cardiac valve lesions

Source: Reactions, Volume 1, Number 1158, 2007-06-30 , pp. 5-5(1)

Publisher: Adis International

Matrix Effect and Cross-Reactivity of Select Amphetamine-Type Substances, Designer Analogues, and Putrefactive Amines using the Bio-Quant Direct ELISA Presumptive Assays for Amphetamine and Methamphetamine

Authors: Apollonio, Luigino G.; Whittall, Ian R.; Pianca, Dennis J.; Kyd, Jennelle M.; Maher, William A.

Source: Journal of Analytical Toxicology, Volume 31, Number 4, May 2007 , pp. 208-213(6)

Publisher: Preston Publications

An update on the pharmacological treatment of obesity

Authors: Schnee, David M.; Zaiken, Kathy; McCloskey, William W.

Source: Current Medical Research and Opinion, Volume 22, Number 8, August 2006 , pp. 1463-1474(12)

Publisher: Informa Healthcare

Heart Failure Induced by Non-Cardiac Drugs

Authors: Slørdal, Lars; Spigset, Olav

Source: Drug Safety, Volume 29, Number 7, 2006 , pp. 567-586(20)

Publisher: Adis International

Topiramate/phentermine combination effective for obesity

Source: Inpharma, Volume 1, Number 1539, 2006-05-27 , pp. 6-6(1)

Publisher: Adis International

Central nervous system biogenic amine targets for control of appetite and energy expenditure

Authors: Nelson, David; Gehlert, Donald

Source: Endocrine, Volume 29, Number 1, February 2006 , pp. 49-60(12)

Publisher: Humana Press

Safety of Drug Therapies Used for Weight Loss and Treatment of Obesity

Authors: Ioannides-Demos, Lisa L.; Proietto, Joseph; Tonkin, Andrew M.; McNeil, John J.

Source: Drug Safety, Volume 29, Number 4, 2006 , pp. 277-302(26)

Publisher: Adis International

Fat Pills for Obesity's Ills: Novel Weight-Loss Drugs Emerging from the Pipeline

Author: Adis International Limited,

Source: Pharmaceutical & Diagnostic Innovation, Volume 4, Number 2, 2006 , pp. 7-9(3)

Publisher: Adis International

Phentermine: First report of optic nerve disorders: case report

Source: Reactions, Volume 1, Number 1084, 2006-01-14 , pp. 20-20(1)

Publisher: Adis International

Radiation Recall Dermatitis after the Use of the Anorexiant Phentermine in a Patient with Breast Cancer

Source: The Breast Journal, Volume 12, Number 2, March 2006 , pp. 186-187(2)

Publisher: Blackwell Publishing